Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Implant endosseous root-form

OsseoSpeed TX 4.0S - 13 mm: medical device reports filed with FDA

1,861 reports name it, 2019–2026. Manufacturer given most often on reports: Dentsply Implants Manufacturing. Product code DZE.

1,861
device reports naming the brand
0% of all MAUDE reports · about 263 a year
187
reports, 12 months to August 2026
228 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 1,861 reports that name the brand "OsseoSpeed TX 4.0S - 13 mm" (implant endosseous root-form), received between June 2019 and August 2026; the manufacturer given most often on reports is Dentsply Implants Manufacturing. Spellings of one product vary from report to report.

187 reports arrived in the 12 months to August 2026, down 18% from 228 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are osseointegration problem (39.1%), loss of osseointegration (32%) and failure to osseointegrate (27.7%). The patient problems coded most often are failure of implant, inflammation and pocket erosion. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02856Sep 2021: 14Oct 2021: 18Nov 2021: 22Dec 2021: 142022Jan 2022: 33Feb 2022: 16Mar 2022: 24Apr 2022: 26May 2022: 26Jun 2022: 16Jul 2022: 9Aug 2022: 20Sep 2022: 17Oct 2022: 16Nov 2022: 25Dec 2022: 272023Jan 2023: 43Feb 2023: 32Mar 2023: 19Apr 2023: 11May 2023: 12Jun 2023: 21Jul 2023: 18Aug 2023: 56Sep 2023: 23Oct 2023: 14Nov 2023: 20Dec 2023: 142024Jan 2024: 39Feb 2024: 31Mar 2024: 27Apr 2024: 32May 2024: 23Jun 2024: 23Jul 2024: 20Aug 2024: 35Sep 2024: 29Oct 2024: 20Nov 2024: 25Dec 2024: 142025Jan 2025: 23Feb 2025: 18Mar 2025: 28Apr 2025: 9May 2025: 15Jun 2025: 14Jul 2025: 15Aug 2025: 18Sep 2025: 18Oct 2025: 10Nov 2025: 13Dec 2025: 252026Jan 2026: 12Feb 2026: 12Mar 2026: 10Apr 2026: 15May 2026: 16Jun 2026: 17Jul 2026: 25Aug 2026: 14

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03176342019: 4420192021: 63420212022: 25520222023: 28320232024: 31820242025: 20620252026: 1212026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%1,861
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%1,861
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Osseointegration problem72839.1%7.7%
Loss of osseointegration59632%22.4%
Failure to osseointegrate51627.7%62.8%
Fracturea broken bone281.5%1.6%
Loosening of implant not related to bone-ingrowth50.3%0.1%
Insufficient device problem information40.2%0.2%
Device dislodged or dislocated30.2%0%
Damaged thread20.1%0%
Crackthe device cracked10.1%0%
Malposition of device10.1%0.1%
Off-label use10.1%0%
Positioning problem10.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant1,85799.8%
Inflammationinflammation27114.6%
Pocket erosion1045.6%
Osteolysis894.8%
Implant pain40.2%
Erosion10.1%
Fistula10.1%
Swelling/ edema10.1%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureOsseoSpeed TX 4.0S - 13 mmProduct code DZEAll MAUDE reports
Reports1,8613,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer100%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about OsseoSpeed TX 4.0S - 13 mm reports

How many FDA reports name OsseoSpeed TX 4.0S - 13 mm?

1,861 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 187 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

osseointegration problem (39.1%), loss of osseointegration (32%), failure to osseointegrate (27.7%), fracture (1.5%) and loosening of implant not related to bone-ingrowth (0.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that OsseoSpeed TX 4.0S - 13 mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.